![CDER's Accelerating Rare Disease Cure (ARC) Program leadership shares first year achievements and plans for second year](https://public4.pagefreezer.com:443/content/FDA/14-06-2023T12:27/https://www.fda.gov/files/styles/medium_3/public/OND_ARC_ProgramAnniversary_1600x900px_230605_1.png?itok=aUY5DQpv)
FDA Voices offers insights into the ARC program's journey and future
June 13 - Learn about program initiatives to drive rare disease drug development
June 13 - Learn about program initiatives to drive rare disease drug development
June 12 - FC is a common condition experienced by children and adolescents
June 7 - Event will review scientific, regulatory, and clinical considerations
June 6 - Guidance ensures participant safety and reliability of clinical trials
May 31 - These recommendations can improve detection of treatment effects
May 30 - Rule ensures patients receive essential prescription drug information
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.